Hoja Patterson

640 total citations
21 papers, 477 citations indexed

About

Hoja Patterson is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Hoja Patterson has authored 21 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Hoja Patterson's work include Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (12 papers) and Fungal Biology and Applications (4 papers). Hoja Patterson is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (12 papers) and Fungal Biology and Applications (4 papers). Hoja Patterson collaborates with scholars based in United States, Iran and Japan. Hoja Patterson's co-authors include Nathan P. Wiederhold, Thomas F. Patterson, Carmita Sanders, Connie Cañete‐Gibas, James Mele, Hongxin Fan, Gabriel Catano, Marcos Olivo, Laura K. Najvar and Marjorie David and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Hoja Patterson

19 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hoja Patterson United States	11	388	350	90	47	42	21	477
Min Ji Choi South Korea	13	454 1.2×	381 1.1×	94 1.0×	54 1.1×	29 0.7×	28	546
Neelam Sachdeva India	7	512 1.3×	419 1.2×	60 0.7×	45 1.0×	22 0.5×	13	599
Catiana Dudiuk Argentina	13	404 1.0×	306 0.9×	73 0.8×	35 0.7×	22 0.5×	21	444
Shalini Upadhyay India	5	504 1.3×	410 1.2×	47 0.5×	46 1.0×	27 0.6×	17	573
Steve L. Kelly United Kingdom	6	326 0.8×	256 0.7×	38 0.4×	49 1.0×	26 0.6×	6	368
Marcos Olivo United States	16	590 1.5×	495 1.4×	44 0.5×	53 1.1×	51 1.2×	19	624
Lucas Xavier Bonfietti Brazil	11	388 1.0×	350 1.0×	76 0.8×	51 1.1×	20 0.5×	28	521
Sondus Alkhazraji United States	13	586 1.5×	422 1.2×	51 0.6×	65 1.4×	36 0.9×	28	669
Gerhard Blum Austria	12	350 0.9×	228 0.7×	79 0.9×	67 1.4×	23 0.5×	16	464
S. Arıkan Türkiye	12	330 0.9×	284 0.8×	77 0.9×	49 1.0×	17 0.4×	22	453

Countries citing papers authored by Hoja Patterson

Since Specialization

Citations

This map shows the geographic impact of Hoja Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoja Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoja Patterson more than expected).

Fields of papers citing papers by Hoja Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoja Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoja Patterson. The network helps show where Hoja Patterson may publish in the future.

Co-authorship network of co-authors of Hoja Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Hoja Patterson. A scholar is included among the top collaborators of Hoja Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoja Patterson. Hoja Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gebremariam, Teclegiorgis, Yiyou Gu, Hoja Patterson, et al.. (2025). Efficacy assessments of SF001, a next-generation polyene antifungal, in a neutropenic mouse model of invasive fusariosis. Antimicrobial Agents and Chemotherapy. 69(5). e0180224–e0180224.

Malwal, Satish R., Rocio Garcia‐Rubio, Milena Kordalewska, et al.. (2025). Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi. ACS Infectious Diseases. 11(6). 1662–1672. 1 indexed citations

Barker, Katherine S., Hoja Patterson, Joachim Morschhäuser, et al.. (2025). Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris ( Candidozyma auris ), Candida albicans , Candida parapsilosis , and Candida glabrata ( Nakaseomyces glabratus ). Antimicrobial Agents and Chemotherapy. 69(9). e0068025–e0068025.

Wiederhold, Nathan P., et al.. (2024). Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole has reduced activity. Antimicrobial Agents and Chemotherapy. 69(1). e0098824–e0098824. 4 indexed citations

Wall, Gina, Bruna Vidal Bonifácio, Ashok K. Chaturvedi, et al.. (2023). High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms. Journal of Fungi. 9(9). 879–879. 7 indexed citations

Cañete‐Gibas, Connie, Hoja Patterson, Carmita Sanders, et al.. (2023). Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov.. Pathogens. 12(4). 579–579. 6 indexed citations

Cañete‐Gibas, Connie, James Mele, Hoja Patterson, et al.. (2023). Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America. Journal of Clinical Microbiology. 61(8). e0056223–e0056223. 54 indexed citations

Wiederhold, Nathan P., Hoja Patterson, Carmita Sanders, & Connie Cañete‐Gibas. (2022). Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species. Mycoses. 66(3). 242–248. 14 indexed citations

Badali, Hamid, Connie Cañete‐Gibas, Dora I. McCarthy, et al.. (2022). Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States. Journal of Clinical Microbiology. 60(5). e0028022–e0028022. 28 indexed citations

10.

Qian, Jian, Nathan P. Wiederhold, Thomas F. Patterson, Hoja Patterson, & Cory Berkland. (2021). Polymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent. ACS Applied Polymer Materials. 3(12). 6034–6039. 5 indexed citations

11.

Badali, Hamid, Connie Cañete‐Gibas, Dora I. McCarthy, et al.. (2021). Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States. Journal of Clinical Microbiology. 59(9). e0123021–e0123021. 46 indexed citations

12.

Badali, Hamid, Hoja Patterson, Carmita Sanders, et al.. (2021). Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In Vitro Activity against Members of the Fusarium oxysporum and Fusarium solani Species Complexes. Antimicrobial Agents and Chemotherapy. 65(6). 21 indexed citations

13.

Badali, Hamid, Connie Cañete‐Gibas, Hoja Patterson, et al.. (2021). In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes. Mycoses. 64(7). 748–752. 28 indexed citations

14.

Wiederhold, Nathan P., Laura K. Najvar, Marcos Olivo, et al.. (2021). Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis. Antimicrobial Agents and Chemotherapy. 65(6). 37 indexed citations

15.

Al‐Obaidi, Mohanad, Hamid Badali, Connie Cañete‐Gibas, Hoja Patterson, & Nathan P. Wiederhold. (2021). Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature. Mycoses. 64(6). 616–623. 3 indexed citations

16.

Badali, Hamid, Hoja Patterson, Carmita Sanders, et al.. (2020). 1282. Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In vitro Activity Against Members of the Fusarium oxysporum and Fusarium solani Species Complexes. Open Forum Infectious Diseases. 7(Supplement_1). S656–S656. 1 indexed citations

17.

Wiederhold, Nathan P., Laura K. Najvar, Rosie Jaramillo, et al.. (2019). The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris. Antimicrobial Agents and Chemotherapy. 64(3). 39 indexed citations

18.

Wiederhold, Nathan P., Laura K. Najvar, Karen Joy Shaw, et al.. (2019). Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis. Antimicrobial Agents and Chemotherapy. 63(11). 51 indexed citations

19.

Wall, Gina, Ashok K. Chaturvedi, Floyd L. Wormley, et al.. (2018). Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development. Antimicrobial Agents and Chemotherapy. 62(10). 75 indexed citations

20.

Wiederhold, Nathan P., et al.. (2017). Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus. Journal of Antimicrobial Chemotherapy. 73(2). 404–408. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact